MarketLens

Why Are Analysts So Bullish on Sagimet Biosciences (SGMT)

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Why Are Analysts Bullish on Cullinan Therapeutics (CGEM)

5 months ago

Why is Goldman Sachs so Bullish on Gold

5 months ago

Why Are Wall Street Analysts Bullish on These Three Stocks

5 months ago

Why Are Barclays Analysts Bullish on Eli Lilly and Bristol-Myers Squibb

5 months ago

1 Top Wall Street Analyst Thinks This Stock Could Soar 95% Over the Next 12 Months. Here's Why I Agree.

A top Wall Street analyst sees 95% upside over 12 months for this stock, citing FDA decisions and revenue expected to nearly double this year. The bullish view hinges on regulatory catalysts and stron...

BBIO

Stock News•2 months ago

Wall Street Bulls Look Optimistic About SentinelOne (S): Should You Buy?

SentinelOne (S) has received bullish ratings from Wall Street analysts, which could influence investor sentiment and stock price.

Stock News•3 months ago

Sagimet Biosciences: Making The Bull Case For Differentiated Denifanstat

Sagimet Biosciences received a new Buy rating based on the clinical potential of denifanstat in MASH and acne treatments. The drug met all primary endpoints in Phase 2b MASH and Phase 3 China acne tri...

SGMT

Stock News•3 months ago

Does Sagimet Biosciences Inc. (SGMT) Have the Potential to Rally 241.77% as Wall Street Analysts Expect?

Sagimet Biosciences Inc. (SGMT) shares face a potential 241.8% upside based on the mean of current Wall Street analyst price targets. This outlook is supported by a consensus among analysts to raise e...

SGMT